UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., and Avid Bioservices, Inc., announced that they have entered into a process development and drug substance manufacturing agreement. Under terms of the agreement, Avid will provide Oragenics with analytical method development, process development and drug substance manufacturing services to support the development of Oragenics’ novel … Continue reading Oragenics Signs Process Development and Manufacturing Agreement With Avid Bioservices for Coronavirus Vaccine